Synapse - Works

Results (115370)

Outcomes of reduced elective nodal radiation dose for laryngeal, hypopharyngeal and p16 negative oropharyngeal cancers

Meeting Abstract

Zakeri, K.; Shang, T.; Yu, Y.; Chen, L.; Shamseddine, A.; Kang, J. J.; Tsai, C. J.; Sherman, E.; Wong, R. J.; McBride, S.; more...
International Journal of Radiation Oncology, Biology, Physics (2024)

Fulltext@MSK | Save

A randomized trial of hypofractionated post-mastectomy radiation therapy (PMRT) in women with breast reconstruction (RT CHARM, Alliance A221505)

Meeting Abstract

Poppe, M. M.; Le-Rademacher, J.; Haffty, B. G. Jr; Hansen, E. K.; Agarwal, J.; Wagner, J.; Kong, I.; Armer, J.; Arthur, D. W.; Whelan, T. J.; more...
International Journal of Radiation Oncology, Biology, Physics (2024)

Fulltext@MSK | Save

Initial clinical experience of Cherenkov imaging in subtotal total skin electron therapy identifies opportunities to improve daily set-up QA

Meeting Abstract

Byrd, B.; Zhu, Y.; Alexander, D. A.; Chelius, M.; Freedman, G. M.; LaRiviere, M. J.; Plastaras, J. P.; Zhu, T.
International Journal of Radiation Oncology, Biology, Physics (2024)

Fulltext@MSK | Save

Safety profile of durvalumab (D) as consolidation treatment (tx) in limited-stage small-cell lung cancer (LS-SCLC) in ADRIATIC: Focus on pneumonitis and immune mediated adverse events (imAEs)

Meeting Abstract

Iyengar, P.; Cheng, Y.; Spigel, D.; Cho, B. C.; Laktionov, K.; Chen, Y.; Lee, K. H.; Buchmeier, E.; Villanueva Palicio, N.; Okamoto, I.; more...
International Journal of Radiation Oncology, Biology, Physics (2024)

Fulltext@MSK | Save

Dosimetric results for organs at risk (OAR) from radiotherapy dose de-escalation to the subclinical region in HPV-mediated oropharyngeal cancer (HPV+ OPC): A retrospective analysis

Meeting Abstract

Miller, D. G.; Youssef, I.; Kallini, D.; Yu, Y.; Zakeri, K.; Chen, L.; Shamseddine, A.; Gelblum, D.; McBride, S.; Riaz, N.; more...
International Journal of Radiation Oncology, Biology, Physics (2024)

Fulltext@MSK | Save

Effect of time-of-day nivolumab and stereotactic body radiotherapy in metastatic head and neck squamous cell carcinoma: A secondary analysis of a prospective randomized trial